A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This study will assess the pharmacodynamics, pharmacokinetics, safety and efficacy of two different doses of tocilizumab (TCZ) in combination with standard-of-care (SOC) in hospitalized adult participants with moderate to severe COVID-19 pneumonia.
Epistemonikos ID: 9be39b193fd5ed1273300573178b90b70be65611
First added on: Apr 28, 2020